関連する実験動画
Updated: Feb 19, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
19.6K
CDI-DTI:多戦略融合に基づく強力なクロスドメイン解釈可能な薬物標的相互作用予測フレームワーク
Xiangyu Li1, Haojie Yang1, Kaimiao Hu1
1Department of Intelligence and Computing, Tianjin University, 300072 Tianjin, China.
Journal of chemical information and modeling
|February 17, 2026
まとめ
CDI-DTIは,クロスドメインとコールドスタートのパフォーマンスを改善するために,マルチモダルの機能を統合することにより,薬物標的相互作用 (DTI) の予測を強化します. この解釈可能なフレームワークは,薬剤発見アプリケーションの重要な進歩を提供します.
科学分野:
- バイオインフォマティックス
- コンピューティング・ケミストリー
- ドラッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー
背景:
- 薬物標的相互作用 (DTI) の正確な予測は,効率的な薬剤発見に不可欠です.
- 既存のDTI予測方法は,クロスドメインの汎用化,コールドスタートの問題,および解釈可能性の欠如に苦しんでいます.
研究 の 目的:
- DTI予測のための新しいクロスドメイン解釈可能なフレームワークであるCDI-DTIを導入する.
- 一般化および冷却スタートシナリオを含む,現在のDTI予測方法論の限界に対処するために.
主な方法:
- 多戦略的融合アプローチを用いた統合されたマルチモダル機能 (テキスト,構造,機能)
- 初期の特徴の整合と融合のために,マルチソースのクロス注意力メカニズムを使用しました.
- イントラモダルの相互作用とグラム損失のための双方向のクロス注意層と遅い融合のための深直線融合モジュールを使用した.
主要な成果:
- CDI-DTIは,ベンチマークデータセットの既存の方法と比較して優れたパフォーマンスを示しました.
- クロスドメインとコールドスタートのDTI予測タスクで大幅な改善を達成しました.
- 高い解釈可能性が保たれ,実用的な応用が容易になりました.
結論:
- CDI-DTIは,薬物標的相互作用の予測のための堅牢で解釈可能なソリューションを提供します.
- このフレームワークは,DTI予測におけるクロスドメインとコールドスタートの課題を効果的に克服します.
- 薬剤の発見と開発を進めるための貴重なツールです.
さらに関連する動画
関連する概念動画
02:04Protein-protein Interfaces
14.8K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.8K
01:26Drug Discovery: Overview
12.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.1K
01:29Pharmacogenomics: Identification of New Drug Targets
20
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
20
01:26Targets for Drug Action: Overview
10.7K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.7K
01:27Combined Effects of Drugs: Synergism
7.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.0K
01:30Drug toxicity: Drug–Drug Interaction
38
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
38